Study Stopped
problems with recruitment and funding
The Value of PET/CT in Diagnosing Residual Disease in Patients With Spinal Infection
Preliminary Study. The Value of 18F-FDG PET/CT Compared to MRI in Diagnosing Residual Disease in Patients With Spondylodiscitis
1 other identifier
observational
10
1 country
3
Brief Summary
MRI has shoved little correlation with the clinical finding during treatment of spondylodiscitis (infection in the vertebrae and/or discs). Since PET/CT is almost as good as MRI in diagnosing spondylodiscitis the hypothesis and this study is that PET/CT is better in predicting residual disease in patients with spondylodiscitis. Preliminary study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Mar 2012
Shorter than P25 for all trials
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 27, 2012
CompletedStudy Start
First participant enrolled
March 1, 2012
CompletedFirst Posted
Study publicly available on registry
March 2, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2013
CompletedFebruary 18, 2013
February 1, 2013
February 27, 2012
February 15, 2013
Conditions
Eligibility Criteria
10 patients with MRI or PET/CT findings as well as overall clinical assessment compatible with spondylodiscitis.
You may qualify if:
- first case of infectious spondylodiscitis
- MRI or 18-F-FDG PET/CT compatible with spondylodiscitis
- overall assessment compatible with spondylodiscitis
You may not qualify if:
- previous spinal infection (e.g. spondylodiscitis; epidural abscess)
- spinal operation in the previous 6 months
- spinal foreign body
- current malignant disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
department of nuclear medicine, Odense University Hospital
Odense, 5000, Denmark
Department of radiology, Odense University Hospital
Odense, 5000, Denmark
Department of infectious diseases, Odense University Hospital
Odense C, 5000, Denmark
Biospecimen
whole blood
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Court Pedersen, MD, DMSc
department of infectious diseases, Odense University Hospital
- PRINCIPAL INVESTIGATOR
michala Kehrer, MD
Department of infectious diseases, Odense University Hospital, Denmark
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
February 27, 2012
First Posted
March 2, 2012
Study Start
March 1, 2012
Study Completion
March 1, 2013
Last Updated
February 18, 2013
Record last verified: 2013-02